August 2025

UROLOGY

RECENT ADVANCES IN PROSTATE CANCER TREATMENT

Ashley Ross, MD, PhD, joined MEDCast to discuss how trial design, inclusion criteria and endpoints, such as radiographic progression-free survival vs. overall survival, affect clinical decision-making in prostate cancer treatment. Dr. Ross emphasizes the significance of quality-of-life data and highlights the shift from relying solely on androgen deprivation therapy as standard care to adopting combination therapies in the management of prostate cancer. 
Ashley Ross, MD, PhD, Professor of Urology at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like